137 related articles for article (PubMed ID: 24077567)
1. Model selection for prognostic time-to-event gene signature discovery with applications in early breast cancer data.
Ahdesmäki M; Lancashire L; Proutski V; Wilson C; Davison TS; Harkin DP; Kennedy RD
Stat Appl Genet Mol Biol; 2013 Oct; 12(5):619-35. PubMed ID: 24077567
[TBL] [Abstract][Full Text] [Related]
2. Validation of 70-gene prognosis signature in node-negative breast cancer.
Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
[TBL] [Abstract][Full Text] [Related]
3. Including network knowledge into Cox regression models for biomarker signature discovery.
Fröhlich H
Biom J; 2014 Mar; 56(2):287-306. PubMed ID: 24430933
[TBL] [Abstract][Full Text] [Related]
4. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
5. Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures.
Huang CC; Tu SH; Lien HH; Huang CS; Huang CJ; Lai LC; Tsai MH; Chuang EY
Breast Cancer Res Treat; 2014 Sep; 147(2):353-70. PubMed ID: 25158930
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of a 92-probe signature in breast cancer.
Akter S; Choi TG; Nguyen MN; Matondo A; Kim JH; Jo YH; Jo A; Shahid M; Jun DY; Yoo JY; Nguyen NN; Seo SW; Ali L; Lee JS; Yoon KS; Choe W; Kang I; Ha J; Kim J; Kim SS
Oncotarget; 2015 Jun; 6(17):15662-80. PubMed ID: 25883221
[TBL] [Abstract][Full Text] [Related]
7. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
[TBL] [Abstract][Full Text] [Related]
8. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
9. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
[TBL] [Abstract][Full Text] [Related]
11. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
[TBL] [Abstract][Full Text] [Related]
12. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
13. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
14. Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.
Wang C; Tran-Thanh D; Moreno JC; Cawthorn TR; Jacks LM; Wang DY; McCready DR; Done SJ
Breast Cancer Res Treat; 2011 Sep; 129(2):373-86. PubMed ID: 21046228
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling.
Frings O; Augsten M; Tobin NP; Carlson J; Paulsson J; Pena C; Olsson E; Veerla S; Bergh J; Ostman A; Sonnhammer EL
Am J Pathol; 2013 Jun; 182(6):2037-47. PubMed ID: 23583284
[TBL] [Abstract][Full Text] [Related]
16. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity.
Oh E; Choi YL; Park T; Lee S; Nam SJ; Shin YK
Breast Cancer Res Treat; 2012 Apr; 132(2):499-509. PubMed ID: 21667120
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
[TBL] [Abstract][Full Text] [Related]
18. A gene transcription signature of obesity in breast cancer.
Creighton CJ; Sada YH; Zhang Y; Tsimelzon A; Wong H; Dave B; Landis MD; Bear HD; Rodriguez A; Chang JC
Breast Cancer Res Treat; 2012 Apr; 132(3):993-1000. PubMed ID: 21750966
[TBL] [Abstract][Full Text] [Related]
19. Consensus genes of the literature to predict breast cancer recurrence.
Lauss M; Kriegner A; Vierlinger K; Visne I; Yildiz A; Dilaveroglu E; Noehammer C
Breast Cancer Res Treat; 2008 Jul; 110(2):235-44. PubMed ID: 17899371
[TBL] [Abstract][Full Text] [Related]
20. Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes.
Hanker LC; Rody A; Holtrich U; Pusztai L; Ruckhaeberle E; Liedtke C; Ahr A; Heinrich TM; Sänger N; Becker S; Karn T
Breast Cancer Res Treat; 2013 Jan; 137(2):407-16. PubMed ID: 23242614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]